CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,105 | $568.00 | $1.2M | 47,466 |
| 2026-04-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,183 | $568.97 | $1.8M | 44,283 |
| 2026-04-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,056 | $569.97 | $1.2M | 42,227 |
| 2026-04-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,215 | $570.88 | $694K | 41,012 |
| 2026-04-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −459 | $571.68 | $262K | 40,553 |
| 2026-04-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $573.01 | $23K | 40,513 |
| 2026-04-10 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 64,500 | ||
| 2026-04-09 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $135.42 | $1.4M | 28,876 |
| 2026-04-09 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −560 | $574.87 | $322K | 28,316 |
| 2026-04-09 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,956 | $575.53 | $1.1M | 26,360 |
| 2026-04-09 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,586 | $576.63 | $915K | 24,774 |
| 2026-04-09 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,617 | $577.77 | $934K | 23,157 |
| 2026-04-09 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,139 | $578.52 | $659K | 22,018 |
| 2026-04-09 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,224 | $579.75 | $710K | 20,794 |
| 2026-04-09 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,756 | $580.64 | $1.0M | 19,038 |
| 2026-04-09 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −162 | $582.30 | $94K | 18,876 |
| 2026-04-09 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 102,500 | ||
| 2026-04-09 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,260 | $575.04 | $725K | 48,753 |
| 2026-04-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,241 | $575.75 | $715K | 47,512 |
Page 126 of 171 · 3,408 trades